Medicina de Família
Diretriz preliminar da USPSTF recomenda rastreamento de ansiedade e depressão em crianças e adolescentes de 8 a 18 anos de idade.
14 Abr, 2022 | 17:54hDiretrizes preliminares:
Screening for Anxiety in Children and Adolescents – US Preventive Services Task Force
Comentário: USPSTF Recommends Anxiety, Depression Screening for Children – HealthDay
Achados do Global Burden of Disease Study 2019 | Impacto de transtornos mentais, transtornos de uso de substâncias e autolesão entre jovens na Europa, 1990-2019.
14 Abr, 2022 | 17:52hComentário convidado: The burden of young people’s mental health conditions in Europe: No cause for complacency – The Lancet Regional Health Europe
Conteúdos relacionados:
Comentário no Twitter
See our new @IHME_UW analysis from on the #burden of #mentaldisorders, substance use disorders & self-harm among young people in Europe. In 2019 there were 16,983 MDs cases/100.000. In last 30 yrs YLD for eating disorders & drug use disorders increased. https://t.co/hMbHDlPuur pic.twitter.com/Rt4Iq4tpAA
— Maciej Banach (@maciejbanach) April 2, 2022
(Artigos e imagens sob licença de CC BY 4.0)
Estudo randomizado | Intervenção de mudança comportamental baseada em exercícios domiciliares de caminhada aumentaram a distância percorrida em testes de avaliação por adultos com doença arterial periférica.
14 Abr, 2022 | 17:50hEffect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Comentário no Twitter
In this study, among adults with peripheral artery disease, a home-based, #walking #exercise behavior change intervention, compared with usual care, increased 6-minute walking distance at 3 months. https://t.co/5ea3YOWlN0 @LindsayBearne pic.twitter.com/s06ONnki9y
— JAMA (@JAMA_current) April 12, 2022
M-A | Inibidores de SGLT2 estão associados com risco reduzido de hiperpotassemia em pessoas com diabetes tipo 2.
14 Abr, 2022 | 17:44hEstudo randomizado | Dapagliflozina não trouxe melhora significativa para o controle glicêmico de crianças e jovens adultos com diabetes tipo 2.
14 Abr, 2022 | 17:42hEfficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study – The Lancet Diabetes & Endocrinology (link para o resumo – $ para o texto completo)
Revisão | Menos é mais: deprescrição de medicamentos em idosos com doença renal.
14 Abr, 2022 | 17:41hLess is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360
Conteúdos relacionados:
AGA clinical practice update on de-prescribing of proton pump inhibitors.
Development of a metric to detect and decrease low-value prescribing in older adults.
Deprescribing in palliative patients with cancer: a concise review of tools and guidelines.
A narrative review of evidence to guide deprescribing among older adults.
Polypharmacy Management in Older Patients – Mayo Clinic Proceedings
Eliminating Medication Overload: A National Action Plan
Position Statement: Reducing Inappropriate Medication Use & Polypharmacy (vários artigos e comentários sobre o tema)
M-A | Desfechos perinatais adversos associados com terapia antirretroviral baseada em inibidor de protease em gestantes vivendo com HIV.
14 Abr, 2022 | 17:32hComunicado de imprensa: Protease inhibitors safer than thought for pregnant women with HIV – University of Oxford
Tuberculose resistente a medicamentos – Desenvolvimentos mais recentes em epidemiologia, diagnóstico e tratamento.
14 Abr, 2022 | 17:25hConteúdos relacionados:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment
Canadian Tuberculosis Standards – 8th Edition.
Guideline: Treatment of Drug-Resistant Tuberculosis
The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis
Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives
Estudo randomizado | Vacinação em dose única contra o HPV se mostrou efetiva entre mulheres jovens na África.
14 Abr, 2022 | 17:07hEfficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women – NEJM Evidence
Comunicado de imprensa:
Study boosts support for single-dose HPV vaccine regimen – University of Washington
Conteúdo relacionado: Three-year follow-up of 2-dose versus 3-dose HPV vaccine
Comentário no Twitter (fio – clique para saber mais)
🚨 GAME CHANGER 🚨
One-dose Human Papillomavirus (#HPV) vaccine offers solid protection against cervical cancer: WHO https://t.co/3uWlZlCCVK pic.twitter.com/ZKDvpf2qog— World Health Organization (WHO) (@WHO) April 11, 2022